[go: up one dir, main page]

MA29855B1 - Inhibiteurs de l'enzyme integrase du vih - Google Patents

Inhibiteurs de l'enzyme integrase du vih

Info

Publication number
MA29855B1
MA29855B1 MA30821A MA30821A MA29855B1 MA 29855 B1 MA29855 B1 MA 29855B1 MA 30821 A MA30821 A MA 30821A MA 30821 A MA30821 A MA 30821A MA 29855 B1 MA29855 B1 MA 29855B1
Authority
MA
Morocco
Prior art keywords
inhibitors
hiv integrase
integrase enzyme
hiv
enzyme
Prior art date
Application number
MA30821A
Other languages
English (en)
Inventor
Klaus Ruprecht Dress
Ted William Johnson
Michael Bruno Plewe
Steven Paul Tanis
Huichun Zhu
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37684843&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA29855(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of MA29855B1 publication Critical patent/MA29855B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Inhibiteurs de l'enzyme intégrase du VIH La présente invention concerne des composés de formule (I) et leurs sels et produits de solvatation pharmaceutiquement acceptables, leur synthèse et leur utilisation comme modulateurs ou inhibiteurs de l'enzyme consistant en intégrase du virus d'immunodéficience humaine ("VIH").
MA30821A 2005-10-07 2008-04-07 Inhibiteurs de l'enzyme integrase du vih MA29855B1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US72448405P 2005-10-07 2005-10-07
US73070105P 2005-10-26 2005-10-26
US76160506P 2006-01-24 2006-01-24
US82395406P 2006-08-30 2006-08-30
US82637906P 2006-09-20 2006-09-20

Publications (1)

Publication Number Publication Date
MA29855B1 true MA29855B1 (fr) 2008-10-03

Family

ID=37684843

Family Applications (1)

Application Number Title Priority Date Filing Date
MA30821A MA29855B1 (fr) 2005-10-07 2008-04-07 Inhibiteurs de l'enzyme integrase du vih

Country Status (21)

Country Link
US (1) US20070099915A1 (fr)
EP (1) EP1934220A1 (fr)
JP (1) JP2009511463A (fr)
KR (1) KR20080042171A (fr)
AP (1) AP2008004400A0 (fr)
AR (1) AR061398A1 (fr)
AU (1) AU2006300926A1 (fr)
BR (1) BRPI0616657A2 (fr)
CA (1) CA2623506A1 (fr)
CR (1) CR9859A (fr)
EA (1) EA200800758A1 (fr)
IL (1) IL189939A0 (fr)
MA (1) MA29855B1 (fr)
NL (1) NL2000255A1 (fr)
NO (1) NO20081230L (fr)
PE (1) PE20070494A1 (fr)
RS (1) RS20080141A (fr)
SV (1) SV2009002864A (fr)
TW (1) TW200800219A (fr)
UY (1) UY29843A1 (fr)
WO (1) WO2007042883A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602005002746T2 (de) * 2004-04-26 2008-02-07 Pfizer Inc. Inhibitoren des hiv-integrase-enzyms
AU2008350907A1 (en) 2007-12-11 2009-08-27 Viamet Pharmaceuticals, Inc. Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties
CN102532021B (zh) * 2012-01-31 2013-10-16 天津大学 2-烷氧基-3,4-二取代异喹啉-1(2h)-酮类衍生物的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ194747A (en) * 1979-08-29 1988-11-29 Schering Ag 9h-pyrido(3,4-b)indol-3-ylcarboxylic acid derivatives
CA2114728A1 (fr) * 1991-08-08 1993-02-18 Tetsuro Ikekawa Compose carcinostatique et sa production
US5726203A (en) * 1993-07-19 1998-03-10 Li; Zelin Qinghaosu derivatives against AIDS
US6057297A (en) * 1996-08-06 2000-05-02 Polifarma S.P.A. Inhibitor compounds of zinc-dependent metalloproteinases associated with pathological conditions, and therapeutic use thereof
FR2754262B1 (fr) * 1996-10-08 1998-10-30 Synthelabo Derives de 1h-pyrido[3,4-b]indole-4-carboxamide, leur preparation et leur application en therapeutique
US6403347B1 (en) * 1998-02-03 2002-06-11 Merck & Co., Inc. HIV integrase inhibitors
WO2001027309A1 (fr) * 1999-10-13 2001-04-19 Merck & Co., Inc. Inhibiteurs d'integrase de vih
WO2001096283A2 (fr) * 2000-06-16 2001-12-20 Bristol-Myers Squibb Company Inhibiteurs d'integrase du vih
PA8586801A1 (es) * 2002-10-31 2005-02-04 Pfizer Inhibidores de hiv-integrasa, composiciones farmaceuticas y metodos para su uso
EP1590349A1 (fr) * 2003-01-27 2005-11-02 Pfizer Inc. Inhibiteurs de vih-integrase, compositions pharmaceutiques et methodes d'utilisation desdits inhibiteurs
DE602005002746T2 (de) * 2004-04-26 2008-02-07 Pfizer Inc. Inhibitoren des hiv-integrase-enzyms
JP2008512442A (ja) * 2004-09-07 2008-04-24 ファイザー・インク Ｈｉｖインテグラーゼ酵素の阻害剤

Also Published As

Publication number Publication date
NO20081230L (no) 2008-04-08
UY29843A1 (es) 2007-05-31
AP2008004400A0 (en) 2008-04-30
IL189939A0 (en) 2008-08-07
AU2006300926A1 (en) 2007-04-19
NL2000255A1 (nl) 2007-04-11
EP1934220A1 (fr) 2008-06-25
US20070099915A1 (en) 2007-05-03
EA200800758A1 (ru) 2008-08-29
TW200800219A (en) 2008-01-01
BRPI0616657A2 (pt) 2011-06-28
PE20070494A1 (es) 2007-06-13
WO2007042883A1 (fr) 2007-04-19
AR061398A1 (es) 2008-08-27
CR9859A (es) 2008-06-20
CA2623506A1 (fr) 2007-04-19
KR20080042171A (ko) 2008-05-14
SV2009002864A (es) 2009-02-19
RS20080141A (sr) 2009-07-15
JP2009511463A (ja) 2009-03-19

Similar Documents

Publication Publication Date Title
MA29791B1 (fr) Composes therapeutiques.
WO2005103003A3 (fr) Inhibiteurs de l'enzyme integrase du vih
MY146669A (en) Pyrazole derivatives for treating hiv
TNSN07022A1 (fr) Derives de pyridine
MA31419B1 (fr) Derives de pyridine
MX2010009995A (es) Heterociclos puenteados como inhibidores de la integrasa del virus de inmunodeficiencia humana.
TN2011000316A1 (fr) Derives de sulfonamides
MA33209B1 (fr) Inhibiteurs de la replication du virus de l'hepatite c
WO2009146555A8 (fr) Inhibiteurs de l'intégrase du vih, issus de la pyridoxine
MA29926B1 (fr) Derives de pyrazine
MA31906B1 (fr) Inhibiteurs de la replication du virus de limmunodeficience humaine
MX2010005292A (es) Inhibidores de la replicacion del virus de la inmunodeficiencia humana.
WO2004096128A3 (fr) Inhibiteurs de l'integrase du vih
MA30911B1 (fr) Nouveaux derives de sulfonamide en tant qu'antagonistes de bradykinine
TW200512208A (en) Piperazine derivatives
MA31142B1 (fr) Derives heteroaryles de pyrrolidinyl et piperdinyl cetones.
EA200601194A1 (ru) Новые производные бензофурана, используемые для профилактики или лечения нарушений, связанных с 5-ht-рецептором
MA34760B1 (fr) Composés et leurs utilisation
MX2008002234A (es) Inhibidores de sulfonamida n-biciclico puenteados de gamma secretasa.
BR0314860A (pt) Derivados de pirazol
MA29855B1 (fr) Inhibiteurs de l'enzyme integrase du vih
TNSN08154A1 (fr) Inhibiteurs de l'enzyme integrase du vih
BR0314759A (pt) Derivados de pirazol
ATE374775T1 (de) Inhibitoren des hiv-integrase-enzyms
SI1651596T1 (sl) Novi derivati ditiobis aminobutan sulfonatov in sestavki ki jih vsebujejo